Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
Recruiting · NCT07341360 · Registry updated 2026-01-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, pseudomyxoma peritonei | Recruiting | Early phase 1 | 2026-01-14 | NCT07341360 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BeiGene | 47 |
| Oslo University Hospital | 327 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oslo University Hospital HF, Radium | Oslo | Norway | 1 |